Mutations in ANTXR1 cause GAPO syndrome
dc.contributor.author | Stránecký, V. | en_US |
dc.contributor.author | Hoischen, A. | en_US |
dc.contributor.author | Hartmannová, H. | en_US |
dc.contributor.author | Zaki, M.S. | en_US |
dc.contributor.author | Chaudhary, A. | en_US |
dc.contributor.author | Zudaire, E. | en_US |
dc.contributor.author | Nosková, L. | en_US |
dc.contributor.author | Barešová, V. | en_US |
dc.contributor.author | Přistoupilová, A. | en_US |
dc.contributor.author | Hodaňová, K. | en_US |
dc.contributor.author | Sovová, J. | en_US |
dc.contributor.author | Hůlková, H. | en_US |
dc.contributor.author | Piherová, L. | en_US |
dc.contributor.author | Hehir-Kwa, J.Y. | en_US |
dc.contributor.author | de Silva, D. | en_US |
dc.contributor.author | Senanayake, M.P. | en_US |
dc.contributor.author | Farrag, S. | en_US |
dc.contributor.author | Zeman, J. | en_US |
dc.contributor.author | Martásek, P. | en_US |
dc.contributor.author | Baxová, A. | en_US |
dc.contributor.author | Afifi, H.H. | en_US |
dc.contributor.author | St Croix, B. | en_US |
dc.contributor.author | Brunner, H.G. | en_US |
dc.contributor.author | Temtamy, S. | en_US |
dc.contributor.author | Kmoch, S. | en_US |
dc.creator.corporateauthor | American Society of Human Genetics | en_US |
dc.date.accessioned | 2014-10-29T09:41:36Z | |
dc.date.available | 2014-10-29T09:41:36Z | |
dc.date.issued | 2013 | en_US |
dc.description.abstract | The genetic cause of GAPO syndrome, a condition characterized by growth retardation, alopecia, pseudoanodontia, and progressive visual impairment, has not previously been identified. We studied four ethnically unrelated affected individuals and identified homozygous nonsensemutations (c.262C>T [p.Arg88*] and c.505C>T [p.Arg169*]) or splicing mutations (c.1435-12A>G [p.Gly479Phefs*119]) in ANTXR1, which encodes anthrax toxin receptor 1. The nonsense mutations predictably trigger nonsense-mediated mRNA decay, resulting in the loss ofANTXR1. The transcript with the splicing mutation theoretically encodes a truncated ANTXR1 containing a neopeptide composed of 118 unique amino acids in its C terminus. GAPO syndrome's major phenotypic features, which include dental abnormalities and the accumulation of extracellular matrix, recapitulate those found in Antxr1-mutant mice and point toward an underlying defect in extracellular-matrix regulation. Thus, we propose that mutations affecting ANTXR1 function are responsible for this disease's characteristic generalized defect in extracellular-matrix homeostasis | |
dc.identifier.citation | American Journal of Human Genetics; 92(5): pp.792-9 | en_US |
dc.identifier.department | Physiology | en_US |
dc.identifier.issn | 0002-9297 (Print) | en_US |
dc.identifier.issn | 1537-6605 (Electronic) | en_US |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/2291 | |
dc.publisher | University of Chicago Press | en_US |
dc.title | Mutations in ANTXR1 cause GAPO syndrome | en_US |
dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: